ArticleJournal of global health2025
Exploring potential barriers and facilitators to integrate tuberculosis, diabetes mellitus, and tobacco control programmes in India.
Article in Journal of global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Burden of multidrug-resistant and extensively drug-resistant tuberculosis in China, India and Russia: estimates from the GBD 2023 study.Journal of thoracic disease · 2026Article
- Integrated tuberculosis-multimorbidity management in India: A SWOT analysis.The Indian journal of medical research · 2026Review
- Readiness assessment as a strategy, not an afterthought: leveraging implementation science to integrate tuberculosis comorbidity care in Pakistan's health system.Frontiers in tuberculosis · 2026Article
- Implementation Determinants of Integrated Tuberculosis and Diabetes Care in South Asian Association for Regional Cooperation (SAARC) Countries: A Systematic Review.International journal of integrated careArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Co-integrating tuberculosis (TB), diabetes mellitus (DM), and tobacco control (TC) programmes in India could help address the triple burden of these diseases. However, limited information exists regarding the feasibility and determining factors of such integration. We explored potential barriers and facilitators to integrating TB, DM, and TC programmes in Ambegaon Block of Pune District, Maharashtra, and Ballabgarh Block of Faridabad District, Haryana, in India. Methods: We conducted a qualitative study based on in-depth interviews with health workers, programme managers, and stakeholders involved in TB, DM, and TC programme implementation whom we enrolled using purposive and snowball sampling. The interview guide was based on World Health Organization's Health System Strengthening framework. We collected the data between November 2022 and March 2023 and analysed it through the rapid analysis method. Results: We interviewed 32 participants. The major challenge for integration, according to the participants' perspectives, relates to the level of service delivery, which is primarily attributed to inadequate implementation of all the programmes. Themes that emerged as facilitators were well-designed programmes with robust guidelines and ample space for infrastructure, while those seen as barriers included inadequate referral systems, insufficient infrastructure, limited resources, a shortage of trained staff, and a lack of essential drugs and equipment, all of which impeded the uptake and coverage of services. Conclusions: Our findings highlight the critical importance of addressing barriers and facilitators to implementing programmes in India for tackling the triple burden of TB, DM, and TC. A multidimensional approach and targeted strategies are needed for overcoming these challenges. Sensitising the health system staff, implementing feedback and referral systems, and developing cross-programme digital platforms will offer a roadmap for policymakers and healthcare system managers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.